PK Study of Ticagrelor in Children Aged less than 24 Months, with Sickle Cell Disease (HESTIA4)

Trial Identifier: D5136C00010
Start Date:March 2018
Primary Completion Date: May 2019
Study Completion Date: May 2019
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

English Translation
Arabic Translation
Dutch Translation
French Translation
Italian Translation
Kiswahili Translation
Spanish Translation
English Translation

Trial Locations

Belgium Edegem, Belgium, 2650
Spain Madrid, Spain, 28007
Spain Madrid, Spain, 28041
United Kingdom CARDIFF, United Kingdom, CF14 4XW
United Kingdom London, United Kingdom, SE1 7EH
Italy CATANIA, Italy, 95123
Italy Genova, Italy, 16100
Italy Perugia, Italy, 6132
Italy Verona, Italy, 37126
Lebanon Beirut, Lebanon, 11-0236
Lebanon Tripoli, Lebanon, 1434
Egypt Al Sharkeya, Egypt, 44519
Egypt Alexandria, Egypt, 21131
Egypt Cairo, Egypt, 11562
Ghana Accra, Ghana, 233
Ghana Ho, Ghana, 0
Ghana Kumasi, Ghana, 1934
Ghana Navrongo, Ghana, 0
Kenya Kisumu, Kenya, 40100
Kenya Kisumu, Kenya, 40100
Kenya Nairobi, Kenya, 00100
Kenya Nairobi, Kenya, 00100
Kenya Nairobi, Kenya, 00200
Kenya Siaya, Kenya, 40600